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Abstract
Expression of activity-regulated cytoskeleton associated protein (Arc) is crucial for diverse types of experience-dependent
synaptic plasticity and long-term memory in mammals. However, the mechanisms governing Arc-specific translation are
little understood. Here, we asked whether Arc translation is regulated by microRNAs. Bioinformatic analysis predicted
numerous candidate miRNA binding sites within the Arc 39-untranslated region (UTR). Transfection of the corresponding
microRNAs in human embryonic kidney cells inhibited expression of an Arc 39UTR luciferase reporter from between 10 to
70% across 16 microRNAs tested. Point mutation and deletion of the microRNA-binding seed-region for miR-34a, miR-326,
and miR-19a partially or fully rescued reporter expression. In addition, expression of specific microRNA pairs synergistically
modulated Arc reporter expression. In primary rat hippocampal neuronal cultures, ectopic expression of miR-34a, miR-193a,
or miR-326, downregulated endogenous Arc protein expression in response to BDNF treatment. Conversely, treatment of
neurons with cell-penetrating, peptide nucleic acid (PNA) inhibitors of miR-326 enhanced Arc mRNA expression. BDNF
dramatically upregulated neuronal expression of Arc mRNA and miR-132, a known BDNF-induced miRNA, without affecting
expression of Arc-targeting miRNAs. Developmentally, miR-132 was upregulated at day 10 in vitro whereas Arc-targeting
miRNAs were downregulated. In the adult brain, LTP induction in the dentate gyrus triggered massive upregulation of Arc
and upregulation of miR-132 without affecting levels of mature Arc-targeting miRNAs. Turning to examine miRNA
localization, qPCR analysis of dentate gyrus synaptoneurosome and total lysates fractions demonstrated synaptic
enrichment relative to small nucleolar RNA. In conclusion, we find that Arc is regulated by multiple miRNAs and modulated
by specific miRNA pairs in vitro. Furthermore, we show that, in contrast to miR-132, steady state levels of Arc-targeting
miRNAs do not change in response to activity-dependent expression of Arc in hippocampal neurons in vitro or during LTP in
vivo.
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Introduction
Mounting evidence supports a role for Arc as a vertebrate-
specific gene specialized for mediating activity-dependent synaptic
plasticity [1–4]. Arc synthesis is required for different forms of
protein synthesis-dependent synaptic plasticity including long-term
potentiation (LTP), long-term depression (LTD), and homeostatic
plasticity, as well as postnatal development of the visual cortex and
multiple forms of long-term memory [5–9]. Furthermore, animal
disease models link dysregulation of Arc protein expression to
Angelman mental retardation syndrome, Alzheimer’s disease,
syndromic autism, seizure development, and anxiety-like behavior
[10–14].
Arc is rapidly induced as an immediate early gene whereupon a
fraction of the new RNA is transported to dendrites for local
storage, translation, or decay, probably in a stimulus-specific and
context-specific manner [3,7,15–18]. Each step in the life of Arc
mRNA is subject to tight control, but the mechanisms are still only
partly understood. Recently, microRNAs have emerged as major
modulators of protein expression levels in the mammalian brain.
The present study sought to elucidate a possible role for
microRNAs as modulators of Arc.
miRNAs are small endogenous non-coding regulatory RNAs
(21–23 nt) that bind to imperfectly complementary sequences in
the 39UTR of target genes and inhibit protein expression.
miRNAs function by recruiting the RNA-induced silencing
complex (miRISC), which represses translation or promotes
mRNA decay [19,20]. Many new brain-specific miRNA families
have appeared in the vertebrate evolutionary line, with diversity
increasing in non-human primates and humans, suggesting that
miRNA evolution is an ongoing process linked to greater brain
complexity [21,22]. The vertebrate genome harbors more than
1500 miRNA genes and each miRNA is bioinformatically
predicted to target hundreds of mRNAs. This suggests an
elaborate net of regulation with many mRNAs targeted by
multiple microRNAs, but so far relatively few miRNA/target
interactions have been experimentally validated in the nervous
system. MicroRNA activity can be modulated by changes in
PLoS ONE | www.plosone.org 1 July 2012 | Volume 7 | Issue 7 | e41688
mature miRNA biogenesis, access of miRNA to target, or
regulation of RISC effector proteins [23–28]. In recent years,
roles for specific microRNAs in neurogenesis, dendritic spine
morphogenesis, synaptic regulation, plasticity, and memory have
been demonstrated [29–38].
As a recently evolved ‘‘master’’ regulator of synaptic plasticity,
Arc is an excellent candidate for elucidating microRNA regulation
and function in the context of complex behaviors and cognition.
The present study demonstrates miRNA regulation of Arc and
suggests a graded control mediated by multiple miRNAs with
different developmental and subcellular expression profiles.
Furthermore, activity-dependent upregulation of Arc is not
associated with altered miRNA expression in vitro or in vivo.
Materials and Methods
Ethics statement
Animal experiments were carried out in accordance with the
European Community Council Directive of 24 November 1986
(86/609/EEC) and approved by the Norwegian Committee for
Animal Research.
Cell culture
Human embryonic kidney cells (HEK293T; American Type
Culture Collection number CRL-11268; www.atcc.org) were
maintained in Dulbecco’s modified Eagle medium (DMEM,
Sigma) supplemented with 10% heat-inactivated fetal calf serum
(Sigma), 100 U/ml penicillin (Sigma), 100 mg/ml streptomycin
(Sigma) and 1 mM L-glutamine at 37uC and 5% CO2. Cells were
seeded in 96-well plates for luciferase reporter assays.
Hippocampal neurons in dispersed culture were prepared with
slight modifications from the protocol originally described by
Banker and co-workers (Banker and Cowan 1977; Kaech and
Banker 2006). Hippocampi of Wistar rat embryos (E18) were
dissected and dissociated by trypsin treatment followed by
trituration. After removal of trypsin, neurons were plated at a
density of 60,000 cells/well on 10 mm diameter cover slips for
imaging experiments or at a density of 240,000 cells/well in a 6-
well plate for biochemical analysis. Both cover slips and 6-well
plates were precoated with poly-D-lysine (Sigma). The cultures
were maintained in MEM (M2279, Sigma) growth medium
supplemented with B-27 supplement (B-27H Supplement, Invitro-
gen), sodium bicarbonate, glucose, and pyruvate, that had been
conditioned on astrocyte cultures for 3 days. Half of the neuronal
growth medium was replaced with fresh growth medium twice a
week. BDNF (100 ng/ml) was applied for 30 minutes, 3 hours, or
4 hours.
Prediction of microRNAs targeting the Arc 39UTR
A list of 16 microRNAs predicted to target the Arc 39UTR was
generated from a larger set of microRNAs obtained by several
different bioinformatic tools. RNAHybrid with default settings was
used in combination with Crosslink software. Candidate micro-
RNAs were also predicted by TargetScan (Release 4.2, April 2008)
and miRanda (Release September 2008).
Cloning and plasmids
MicroRNA constructs. Human and rat genomic DNA was
isolated using Gene Elute Genomic DNA Mini Kit (Sigma) and
used as template for cloning of a panel of pri-microRNAs. The pri-
miRNA was cloned into the lentiviral p232 construct kindly
provided by Stephen Elledge. For overexpression of miR-19a
precursor a commercial construct (RmiR6091-MR04) was used
(GeneCopoeia, Rockville, MD).
Gaussia Luciferase reporter vector. The reporter vector
pcDNAGluc encoding secreted Gaussia luciferase (Gluc) was
made by subcloning a HindIII-Not1 Gluc fragment from pNEBR-
X1Gluc (NEB, Ipswich, USA) into pcDNA3.1 (Invitrogen,
Carlsbad USA). The complete Arc 39UTR was amplified from
rat brain cDNA using specific primers with Xho1 and EcoRI
overhang and cloned into the reporter vector pcDNA3.1Gluc
downstream of the Gluc reporter gene.
Site-directed mutation (SDM) constructs. Site-directed
mutagenesis of the microRNA seed-binding regions (correspond-
ing to three nucleotides in the seed sequence) and deletion
constructs were generated using the QuickChange SDM kit
(Stratagene, La Jolla, CA).
All constructs were confirmed by DNA sequencing. Primers are
available on request.
Cell transfection experiments and reporter assays
Reporter luciferase assay. HEK-293T cells (American
Type Culture Collection number CRL-11268) were seeded in
96-well plates and transiently transfected with Gaussia luciferase
reporter (20 ng) constructs, microRNA vectors (100 ng), and
gWIZ SEAP Mammalian Expression Vector (10 ng) (P050200,
Genlantis, San Diego, CA, USA) using FuGENEH HD transfec-
tion reagent (Roche). Gaussia luciferase is a secreted luciferase and
48 hours after transfection medium was collected and Gluc
activity was measured using BioLuxH Gaussia Luciferase Assay
Kit (NEB, Ipswich, MA) according to the manufacturer’s protocol.
The activity of gWIZ Secreted Alkaline Phosphatase (SEAP) was
used for normalization of transfection efficiency.
Transfection of primary hippocampal cell cultures with
microRNA vectors. Two slightly different experiments were
carried out to look at the effect of endogenous Arc expression after
overexpression of microRNAs. After 7 days in vitro (DIV7),
neurons were transfected with plasmids expressing DsRed only
(empty vector), ds-Red-miR-150, DsRed-miR-326 or DsRed-miR-
193a using Lipofectamine-2000 Reagent (Invitrogen). One day
before transfection the medium was changed and replaced with
fresh medium containing 2 mg/ml vitamin C. In the second set of
experiments neurons were transfected with DsRed only, DsRed-
miR150, or DsRed-miR34a using Lipofectamine LTX and Plus
Reagent (Invitrogen) according to manufacturer’s instructions.
Three days after transfection, human BDNF (Alomone labs B-250)
was added to a final concentration of 100 ng/ml for four hours to
induce expression of Arc [39]. For immunocytochemistry, cells
were washed with phosphate buffered saline (PBS), fixed with 4%
paraformaldehyde/sucrose/PBS for 15 minutes, treated with
50 mM ammonium chloride/PBS for 10 minutes, permeabilized
with 0.1% Triton X-100/PBS for 5 minutes, and blocked with
0.5% bovine serum albumin (BSA)/PBS for 30 minutes. Antibod-
ies were diluted in 0.5% BSA/PBS. Primary antibody: Arc C-7
(Santa Cruz Biotechnology, sc-17839), 1:200, overnight at 4uC.
Secondary antibody: donkey anti-mouse coupled to Alexa Fluor
647 (Invitrogen A31571), 1:500, 30 minutes at room temperature.
In the first set of experiments Phalloidin FITC (Sigma, P5282) was
added at a 1:40 dilution to simplify the identification of the cells.
Coverslips were washed in ddH2O and mounted in ProLongGold
antifade mounting medium containing DAPI (Invitrogen).
Imaging and image analysis
Imaging was done with a Zeiss Axio Imager Z1 upright
fluorescence microscope equipped with a mercury arc lamp (HXP
120), a 406oil immersion objective (EC Plan-NEO FLUAR 406/
1.3 Oil), single pass fluorescent filters for DAPI (488049-0000),
DsRed (1114-101), infrared (488050-0000) and FITC (1114-459)
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spectra, and a CCD camera (AxioCam MRm). For each
experiment, exposure times were carefully chosen to avoid
saturation and all images were taken on the same day using the
same exposure times. Microscopy images were analysed using the
open source software CellProfiler (www.cellprofiler.org). For the
miR-34a experiments nuclei were automatically identified from
the DAPI images. They were used as seed regions in the Arc/
AF647-stained image to automatically identify the outlines of the
neurons using a watershed segmentation algorithm. The image
was discarded when the segmentation algorithm failed. For each
cell, the area, mean Arc/AF647 intensity, mean DsRed intensity
and the respective standard deviations were measured. For miR-
326 and miR-193a, CellProfiler threshold detection was used to
separate the nuclear and cytoplasmic signals. In order for the
nucleus-seed-algorithm to work for all cells, the single channels
(AF647, DsRed) were smoothed, weighed, added and then the
nuclei are used as a seed in this calculated image.
Data analysis: Using Microsoft Excel, the average intensity of
DsRed in non-transfected cells was determined from the
cumulative frequency plot, and the miR-34a transfected cells
were normalized to that value. Arc data were also normalized to
the average value in non-transfected cells. miR-326 and miR-193a
experiments were similarly analyzed but in this series mean values
of cytoplasmic pixels from the 20 highest DsRed expressing cells
were compared with the 20 lowest.
PNA microRNA inhibitors
PNA modified antisense oligonucleotides (PNA-AS) comple-
mentary to miR-326, miR-34a and miR-19a were purchased from
Panagene Inc. (Daejeon, Korea). The oligonucleotide is coupled to
a cell-penetrating peptide RRRQRRKKR (PNATM miRNA
inhibitors) in order to facilitate cellular uptake in difficult to
transfect cells such as primary neurons. The peptide is linked to
the microRNA antisense sequence by an ethylene glycol linker
(EAAE linker). PNA-AS was transfected at a final concentration of
500 nM using Lipofectamine 2000. The transfection mix was
replaced with conditioned growth medium after 3 hours. Cells
were harvested after 48 hours for protein or RNA extraction.
Immunoblot analysis
Antibodies used for western blot analysis were: Arc C7 (sc-
17839,1:500, Santa Cruz Biotech, Santa Cruz CA, USA) and
GAPDH (sc-32233,1:1000, Santa Cruz Biotech, Santa Cruz CA,
USA). Equal amount of samples were loaded onto 10% SDS-
PAGE gels and run for 2.5 to 3 hours at a constant voltage of
100 V. Separated proteins were subjected to western blotting. For
western blotting, separated proteins were transferred to HyBond
ECL nitrocellulose membrane (Amersham, Little Chalfont,UK) at
a constant voltage of 100 V for 1.5 hours. Membranes were
stained with Ponceau to check for proper transfer followed by
blocking with blocking buffer (5% BSA, 0.1% Tween and Tris-
buffered saline (TBST) for 1 hour on a gyro-rocker at room
temperature. The primary and the secondary antibodies were
diluted in 2% BSA in 0.1% TBST. The membranes were
incubated with primary antibody overnight at 4uC with constant
shaking. Following three washes with TBST, blots were incubated
for 1 hour in horseradish peroxidase conjugated secondary
antibody dissolved in 2% BSA in TBST. The blots were washed
three times with TBST and once with 16 TBS and proteins
visualized using enhanced chemiluminescence (ECL Western
Blotting Analysis System, Amersham Pharmacia Biotech, Nor-
way).
Synaptoneurosome preparation
Synaptoneurosomes were prepared by the filtration method
[40,41]. Dentate gyrus tissue samples were homogenized in a
dounce homogenizer in homogenization buffer (final concentra-
tion of 50 mM HEPES pH 7.4, 125 mM NaCl, Sucrose 100 mM,
and EGTA 10 mM). Before homogenization one tablet of protease
inhibitor (Complete, Mini; Protease Inhibitor Cocktail Tablets,
Roche, Mannheim, Germany) and 10 ml RNAase inhibitor
(RiboLockTM RNAse Inhibitor, Fermenta, St. Leon-Rot, Ger-
many) was added to 10 ml of homogenization buffer. An aliquot
was removed for total homogenate comparison. The remaining
homogenate was centrifuged at 2000 g for 1 minute at 4uC. The
supernatant was filtered through two layers of 100 mm nylon filters
(NY1H04700, Millipore, Billerica, MA, USA). A second filtration
was done through one layer of 5 mm PVDF membrane
(SVLP01300, Millipore, Billerica, MA, USA). The filtrate was
then centrifuged at 1000 g for 10 minutes at 4uC. The pellet
containing the synaptoneurosome fraction was dissolved in
homogenization buffer and used for protein analysis or RNA
extraction.
In vivo electrophysiology
The electrophysiology procedures have been detailed elsewhere
[42,43]. Adult male Sprague-Dawley rats weighing 250 g 2350 g
were anesthetized with urethane (1.5 g/kg i.p.) and electrodes
were inserted for selective stimulation of the medial perforant path
and recording of evoked potentials in the hilar region of dentate
gyrus. The HFS paradigm for LTP induction consisted of eight
pulses at 400 Hz, repeated four times at 10 s intervals. Three
sessions of HFS were given, with 5 minutes between each HFS.
LTP induction was performed for various intervals of time before
dissecting out the dentate gyri. Signals from the dentate hilus were
amplified, filtered (1 Hz to 10 kHz), and digitized (25 kHz).
Acquisition and analysis of field potentials were accomplished
using Data Wave Technologies Work Bench Software (Longmont,
CO). The maximum slope of the fEPSP and the amplitude of the
population spike measured from its negative going apex to the
tangent line, joining the first two positive peaks were measured and
the averages of four consecutive responses were obtained. Analysis
of variance (ANOVA) for repeated measures followed by a post
hoc Scheffe´ test was used for statistical analysis of group effects.
Statistics were based on values obtained during the 5 minutes at
the end of baseline.
RNA extraction, reverse transcription and real-time PCR
RNA extraction. Total RNA was extracted from primary
hippocampal cell cultures with TRIzolHreagent (Life technologies,
Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s
instructions. RNA was dissolved in 1 mM EDTA and treated with
TURBO DNA-freeTM Kit (Ambion, Austin, TX) prior to RT-
PCR. To validate the inhibition of microRNAs after PNA AS
transfection, RNA enriched in small RNAs was purified using
PureLinkH miRNA Isolation Kit (Life technologies, Invitrogen,
Carlsbad, CA, USA).
Quantitative real-time PCR for Arc. For measurements of
Arc mRNA, 150 ng of total RNA was used as input for cDNA
synthesis using SuperScriptH III First Strand Synthesis System
(Life technologies, Invitrogen, Carlsbad, CA, USA). The cDNA
was diluted 10-fold and 3 ml was used as template in semi-
quantitative real-time PCR together with LightcyclerH480 DNA
SYBR Green Master Mix (Roche). Semiquantitative real-time
PCR was performed on a Roche LightcyclerH480. Samples were
assayed in triplicates and normalized to the geometric mean of
polyubiquitin and hypoxanthine phosphoribosyltransferase
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(HRPT) or the geometric mean of polyubiqutin, HRPT and
cyclophilin [44]. Primer sequences are found in Table S1.
Taqman miRNA real-time qPCR. Changes in mature
microRNA levels were determined using the TaqManH Micro-
RNA Reverse Transcription Kit and TaqManHmicroRNA Assays
(Applied Biosystems, Foster City, CA) according to manufacturer’s
protocol. 15 ml of cDNA was generated from 30 ng of total RNA
and 3 ml of a 15-fold dilution was used for real-time PCR
reactions. Y1 and snoRNA has been used for normalization.
Changes in relative concentration was calculated with the
second derivative maximum method 22DCT. DCT was calculated
by subtracting the CT of the housekeeping gene from the CT of
the gene of interest. Fold change was generated using the equation
22DDCT. Student’s t-test was used for the statistical analyses.
microRNA in situ hybridization
Rats were intracardially perfused with 4% paraformaldehyde
(PFA). The brain was removed and submerged sequentially in 4%
PFA for 24 hours at 4uC and 30% sucrose for 48 hours at 4uC.
On the following day the brains were frozen in CO2 gas and
30 mm-thick coronal sections were cut on a Leica CM3050S (cryo-
microtome) using Richard-Allan Sec5e blades. Sections were
immediately stored in phosphate buffer containing 0.1% azide at
4uC. In situ hybridization was performed on 30 mm-thick floating
sections using locked nucleic acid (LNA) probes as described
previously [23,45]. The LNA probes were a gift from Dr Thomas
Tuschl’s lab (Rockefeller University, NY, USA).
Sections were rinsed in TBS (Tris-buffered saline) and
incubated with proteinase K for 5 minutes at 37uC, washed twice
in TBS, then post-fixed for 5 minutes in 4% PFA. After washing
once in 0.2% Glycine/TBS and twice in TBS, sections were
incubated in freshly prepared 1-methylimidazole solution, and
then immersed in 1–ethyl–3–(3–dimethylaminopropyl) carbodii-
mide (EDC) fixative for 60 minutes at room temperature (RT).
Sections were washed again, followed by acetylation with
triethanolamine and acetic anhydride, to inactivate endogenous
alkaline phosphates and peroxidases. After 10 minutes of prehy-
bridization, sections were incubated overnight in 4 pmol of LNA
probe diluted in 200 ml hybridization buffer. A hybridization
temperature at 20uC below the Tm of the experimentally
determined miRNA-LNA probe duplex was used. The LNA-
probes were synthesized and melting temperatures were experi-
mentally determined in the Tuschl laboratory [45]. After post-
hybridization washes, the sections were treated with 3% hydrogen
peroxide and washed, before being blocked and incubated with
anti-POD-AP for 1 hour at RT (Roche Diagnostics GmbH,
Mannheim, Germany). Staining of the sections was done using the
TSA Plus Cy3 System (PerkinElmer Life Sciences). Slides for
fluorescent staining were mounted with VectashieldH HardSetTM
mounting medium with DAPI (Vector Laboratories, Inc., CA,
USA).
Target prediction and pathway analysis
To identify the potentially regulated biological pathways of the
Arc-targeting microRNAs they were uploaded into the DIANA-
miRpath tool. The microRNAs included were miR-19a, miR-34a,
miR-193a and miR-326. The target prediction software used for
the pathway analysis was DIANA microT [46]. The pathway
analysis performs enrichment analysis of the miRNA input set to
all available biological pathways in the Kyoto Encyclopedia of
Genes and Genomes (KEGG) [47]. A Pearson’s chi-squared test of
the input dataset gives the number of genes observed to participate
in a given pathway and those expected to occur by chance. The
enrichment is represented by a negative natural logarithm of the
P-value (2ln P).
Results
Multiple miRNAs inhibit Arc 39UTR reporter expression in
HEK cells
Bioinformatic tools (TargetScan, miRanda and RNA hybrid)
based on distinct miRNA target prediction algorithms were used
to generate a list of 66 potential miRNA binding sites in the 1626
nucleotide long Arc 39UTR (NCBI Reference Sequence: NM-
019361.1. Sixteen miRNAs with the greatest predicted efficacy of
targeting were transfected in HEK 293T cells together with a
Gaussia luciferase reporter construct harboring the Arc 39UTR
(Figure 1A). A panel of 7 microRNAs predicted not to bind the
Arc 39UTR was used as a normalization control. The cloned
miRNA precursors were confirmed to be overexpressed by qPCR.
A dynamic range of regulation was observed for the predicted
candidate miRNAs ranging from no effect to a 70% reduction in
mean luciferase expression (Figure 1A).
For further validation we selected the four miRNAs (miR-34a,
miR-193, miR-378, and miR-512-5p) with strongest inhibitory
effect on the Arc 39UTR. miR-19a and miR-326 were added to
this analysis because TargetScan (Release 6.0; November, 2011)
shows a vertebrate-conserved binding site for miR-19a and two
binding sites for miR-326 in the Arc 39UTR. A schematic drawing
of the Arc mRNA showing the position of the selected miRNA
binding sites and alignments between the miRNA sequences and
the Arc 39UTR is shown in Figure 1B.
Regulation of Arc by miR-34 and miR-326 is attenuated
by point mutations and deletion of the microRNA seed
region
To evaluate the interaction between miRNA and Arc 39UTR
we carried out site-directed mutagenesis (SDM) within the seed-
region of the microRNA binding site in the Arc 39UTR. Triplet
substitution mutations were placed within seed nucleotides 2–6
(sites underlined in Figure 1B). These core nucleotides of the seed
are necessary for an efficient interaction between the microRNA
and the target sequence. Using the wildtype Arc 39UTR, we
independently confirmed inhibition of reporter expression by the
candidates selected from Figure 1A and further demonstrated
inhibition by miR-19a and miR-326 (Figure 2A). Introducing
three point mutations in the binding seed resulted in partial but
significant rescue of luciferase expression for miR-34a and miR-
326 (Figure 2A). SDM of the proximal miR-326 site (site S2 in
Figure 1C) did not affect the luciferase activity (data not shown)
whereas mutations directed to the second site resulted in a modest
0.3-fold enhancement in expression relative to wildtype. The
impact of miR-34a site mutation was more pronounced, as
expression in the mutant reporter was significantly enhanced 2-
fold relative to wildtype Arc 39UTR. The miR-34 family has three
members, miR-34a, -34b and -34c, that are predicted to bind the
same sites. We therefore compared the effects of ectopic expression
of miR-34a and miR-34c on Arc expression. miR-34c reduced
wildtype Arc expression to 62% of control levels, whereas miR-34a
expression had a much stronger effect, reducing expression to 18%
of control. Furthermore, point mutation of the miR-34 binding site
rescued inhibition induced by miR-34a, but not miR-34c.
Mutation of the binding sites for miR-193, -378 and -512-5p also
had no effect on reporter expression elicited by the respective
miRNAs.
Introducing nucleotide substitutions in the seed sequence is a
way of partially interfering with the binding between microRNA
MicroRNA Regulation of Arc
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and target. The removal of the whole seed sequence could have a
greater impact. Focusing on miR-34a and miR-326, we compared
the effect of mutagenesis of three nucleotides in the seed binding
region with deletion of the entire seed from the Arc sequence. To
confirm functionality of the microRNA overexpression construct
we co-transfected a luciferase vector harboring a perfectly
complementary binding sequence of the miRNA as a positive
control (sensor). For miR-34a, complete recovery of expression
was obtained in the substitution and deletion mutants (Figure 2B).
Expression of the sensor reporter for miR-34a was effectively
inhibited to approximately 10% of control. More moderate effects
were obtained for miR-326. Triplet substitution mutation of the
distal miR-326 site (S4), deletion of S4, or deletion of S2 failed to
enhance expression relative to wildtype control significantly
(Figure 2C). However, significant recovery of expression was
obtained when both miR-326 binding sites were deleted.
Inhibition of the perfectly matched miR-326 sensor was 70% of
control, approximately equal to effects obtained with the wildtype
Arc 39UTR reporter. Note, however, that miR-34a gave
significantly stronger inhibition of both the wildtype and sensor
constructs. For reasons unclear the substitution mutation proce-
dure did not work for miR-19a. However, complete deletion of the
miR-19a seed resulted in a significant increase in reporter activity
relative to wildtype.
Figure 1. Luciferase reporter screen for microRNAs targeting the Arc 39UTR. A) Arc 39UTR luciferase reporter vector and microRNA
precursor plasmids were co-transfected in HEK293T cells. After 48 h the luciferase activity was measured and normalized to transfection control
(gWIZ, alkaline phosphatase). The luciferase values were further normalized to the average luciferase value obtained after transfecting a panel of
microRNAs not predicted to target the rat Arc 39UTR (rno-miR-370, rno-miR-150, rno-miR-342, rno-miR-30b, rno-miR-105, rno-miR-145 and rno-miR-9).
The candidate Arc-targeting microRNAs produced a graded inhibition of Arc 39UTR luciferase expression ranging from 0 to 70%. B) Schematic
representation of the localization of the seven predicted microRNA binding sites in the Arc 39UTR (NM_019361) that were selected for further studies
with site-directed mutagenesis. The numbering refers to the position in the 39UTR. The nucleotides that were changed by site-directed mutagenesis
are underlined in the alignment.
doi:10.1371/journal.pone.0041688.g001
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Arc regulation is enhanced by expression of specific
microRNA pairs
The complexity of the microRNA system and their diverse roles
in physiology can partly be explained by their combinatorial
effects. Not only can a single microRNA regulate several different
target genes, mRNAs often have binding sites for many different
microRNAs. We decided to explore possible combinatorial
regulation of Arc by miRNAs. Having established the effect of
single microRNAs on Arc, we asked if reporter expression is
modulated by the expression of specific microRNA pairs (Figure 3).
miR-34a and miR-326 were expressed alone and in combination
with other Arc-targeting miRNAs. Co-expression of miR-34a with
miR-19a, miR-378, or miR-326 did not modulate the inhibition
induced by miR-34a expression alone. However, the combination
of miR-34a and miR-193a significantly enhanced repression
relative to miR-34a alone. Inhibition of the Arc 39UTR by
miR-326 was not affected by co-transfection with miR-19a, yet
significantly stronger inhibition was obtained when miR-326 was
paired with miR-193a or miR-378. The results from the reporter
Figure 2. The effects of miR-19a and miR-34a and miR-326 is
dependent on intact microRNA binding sites. A) Site-directed
mutagenesis was carried out to interfere with 6 different microRNA sites
in the Arc 39UTR. Three nucleotides in the seed-binding region of miR-
34, -193, -326, -378 and -512_5p were mutated in the Arc 39UTR and the
whole seed binding region was removed for miR-19. 48 h after co-
transfection of HEK293T cells with Arc reporter constructs (wildtype or
mutated) and microRNA expression vectors, the medium was harvested
for measurement of luciferase and SEAP activity. A significant difference
in luciferase expression was observed after substitution mutation or
deletion of the miRNA binding sites for miR-19a, miR-34a and miR-326
in response to expression of the respective miRNAs, relative to the
wildtype Arc 39UTR. B) Deletion of the miR-34a site resulted in full
recovery of luciferase activity. The positive control comprised of a fully
complementary sensor sequence of miR-34a was efficiently inhibited by
miR-34a overexpression. C) Whereas mutation of the distal (S4) miR-326
site or deletion of either site individually had only minor effects, the
deletion of both sites at the same time gave full recovery of luciferase
activity. The sensor construct of miR-326 showed the same effect as
deleting both miR-326 binding sites. In panels A, B and C luciferase
expression was normalized to the transfection control (gWIZ, alkaline
phosphatase) and to miR-150. miR-150 was one of the miRNAs in the
initial screen with least effect on the luciferase activity of the reporter
vector. Values are means 6 SEM (n= 3). * p,0.05, significantly different
from wildtype (Student’s t-test).
doi:10.1371/journal.pone.0041688.g002
Figure 3. Repression of Arc is enhanced by expression of
microRNA pairs. Arc-targeting microRNAs were overexpressed in
HEK293T cells alone or in pairs. The following combinations: miR-34a/
miR-193a, miR-326/378 and miR-326/193a gave enhanced inhibition of
luciferase activity compared to miR-34a and miR-326 alone. Values are
means 6 SEM (n= 3). *p,0.05, significantly different from miR-34a or
miR-326 alone (Student’s t-test).
doi:10.1371/journal.pone.0041688.g003
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studies suggest highly specific interactions between miRNA pairs
in modulating Arc expression.
miR-34a, miR-326, and 193a downregulate Arc protein in
hippocampal neurons
Next we asked if overexpression of these miRNAs regulates
endogenous Arc expression in neurons. For this purpose E18
primary hippocampal neuronal cultures were transfected with
microRNA expression plasmids, yielding sparsely transfected
neurons suitable for analysis by fluorescence microscopy. DIV7
cultures were transfected with plasmids expressing empty vector,
the control microRNA miR-150, or an Arc-targeting microRNA.
We chose to study miR-34a and miR-326 as strong candidates
from the point mutation analysis and miR-193a because of its
synergistic effects. A red fluorescent label, DsRed, was present on
the plasmids to mark the transfected cells. Arc expression was
induced by a four-hour treatment with BDNF prior to parafor-
maldehyde fixation and imaging of the neurons. While there was
considerable cell-to-cell variation in immunofluorescence for Arc
within treatment groups (Figure 4A and D), automated cell
segmentation of a high sample number demonstrated significant
modulation of endogenous Arc protein expression consistent with
effects obtained in heterologous cells. The levels of Arc protein was
plotted against the level of DsRed expressed after transfection
(Figure 4B). Mean Arc levels were comparable between cells
transfected with empty vector and miR-150 controls, but were
significantly reduced in neurons transfected with miR-34a, miR-
326, or miR-193a (Figure 4C and E). Inhibition ranged between
30 and 60%.
Peptide-nucleic acid miRNA inhibitors enhance
endogenous Arc mRNA expression
Next we sought to inhibit the endogenous miRNAs by
overexpressing antisense oligonucleotides in hippocampal neurons
while measuring the effect on Arc mRNA and protein expression
by qPCR and western blot. Such regulation may be difficult to
detect in lipofectamine transfected neurons with transfection rates
typically below 5%. For that reason we combined lipofectamine
transfection with peptide nucleic acid (PNATM) antisense oligo-
nucleotides (PNA-AS) to inhibit endogenous miRNAs. In PNAs,
cellular uptake is facilitated by conjugation of a cell-penetrating
peptide (CPP) to the antisense oligo. Moreover, replacement of the
phosphate ribose ring of the antisense oligo with a polyamide
backbone of N-(2-aminoethyl) glycine confers greater binding
affinity and stability [48]. The transfection efficiency of a
fluorescein-labeled PNA oligo in hippocampal neurons was
approximately 80% at 24 hours after transfection (Figure 5A).
Unstimulated hippocampal neurons were transfected at DIV8
with PNA-AS complementary to miR-34a, miR-326 and miR-
193a and cells were harvested 48 hours later for qPCR or western
blot. Arc mRNA was significantly increased after treatment with
miR-326, but not miR-34a, PNA-AS (Figure 5C). Transfection of
miR-193a AS resulted in a small but insignificant increase in Arc
mRNA. Surprisingly, no effects were detected at the protein level
(Figure 5D). PNA-AS bound to target microRNAs should prevent
detection of the miRNA by qPCR. We confirmed that PNA-AS
transfection almost completely eliminated PCR-detectable miR-
326, miR-34a and miR-193 (Figure 5B). The corresponding miRs
were observed at considerably higher Ct values after transfecting
miR specific PNAs compared to control (AS-miR34a Ct= 36;
scrambled Ct = 27, AS-miR-326 C=40; scrambled CT=30, AS-
miR-193 CT.40; scrambled CT=35).
Developmental regulation of Arc-targeting miRNAs in
hippocampal neurons in vitro
In the next series of experiments, we sought to gain insight into
the regulation of the Arc-targeting microRNA in vitro and in vivo.
We first examined the developmental regulation of miRNA
expression in hippocampal neurons in vitro. Levels of Arc mRNA
and mature miRNAs were determined by qPCR in E18
hippocampal neuronal cultures at DIV 3, 10, 14 and 21. Arc
mRNA levels elevated at day 10, 14, and 21, relative to day 3
(Figure 6A). Next we looked at the levels of three Arc-targeting
miRNAs over the same time frame. Dramatic changes in mature
miR-19a, miR-34a, miR-326 and miR-193a were observed during
development, with maximum changes of more than 100-fold. Note
that miRNA expression is reported with a log scaled y-axis. At
DIV10, all three miRNAs exhibited significantly decreased
expression relative to DIV3 (Figure 6B). After day 10, the
expression of the miRNAs increased, though levels of miR-326
remained significantly decreased relative to DIV3. Thus, at early
stages of differentiation (DIV3-DIV10) there is an inverse
relationship between expression of Arc-targeting miRNAs and
levels of Arc mRNA. As a positive control we also examined miR-
132, which is known to be developmentally upregulated in
hippocampal neurons [49,50]. We show that, in contrast with the
Arc-targeting miRNAs, miR-132 expression progressively increas-
es during the first three weeks of in vitro development (Figure 6B).
BDNF regulates expression of Arc mRNA, but not of Arc-
targeting miRNAs, in hippocampal neurons
Brain-derived neurotrophic factor (BDNF) can induce the
expression of plasticity-related genes such as Arc and miR-132
in embryonic hippocampal neurons [39,49–51]. We therefore
investigated the effect of BDNF treatment of hippocampal neurons
on expression of Arc-targeting miRNAs, using Arc mRNA and
miR-132 as positive controls. DIV8 neurons were treated with
BDNF for 30 minutes or 3 hours. Arc mRNA was elevated 24-fold
above non-treated control neurons after 30 minutes of BDNF
treatment, declining to a 7-fold increase at 3 hours. Using the
same RNA preparations from whole lysates, we confirmed
significant upregulation of miR-132 at the 30 minutes (1.4 fold)
and 3 hours (2-fold) time points (Figure 7B). In contrast, Arc-
regulating miR-34a, miR-326, miR-19 and miR-193a were not
significantly regulated, although there was trend for miR-34a
upregulation at 30 minutes post-BDNF (p= 0.07).
LTP induction in the dentate gyrus of adult anesthetized
rats upregulates Arc mRNA without regulating
corresponding miRNAs
We then turned to examine microRNA regulation in the intact
adult brain. We asked whether Arc-targeting miRNAs are
regulated in vivo by synaptic stimulation, using LTP in the dentate
gyrus of anesthetized rats as a model system. Brief bursts of high-
frequency stimulation (HFS) applied to the medial perforant path
generated a lasting increase in the slope of the field excitatory
postsynaptic potential (fEPSP). Previous work has shown that Arc
mRNA is strongly induced and transported to dendrites following
HFS, while Arc translation is necessary for LTP consolidation
[7,42,43,52]. LTP in the dentate gyrus is also associated with
upregulation of mature miR-132 at two hours post-HFS [23]. In
the current study, qPCR analysis performed on whole dentate
gyrus lysates confirmed upregulation of Arc mRNA at 30 minutes
and 2 hours post-HFS and upregulation of miR-132 at 2 hours
(Figure 8A and 8B). In contrast, miR-19a, miR-34a, miR-326 and
miR-193a were not significantly regulated. We conclude that
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robust upregulation of Arc mRNA levels is not associated with
detectable changes in the expression of several mature miRNAs
capable of regulating Arc.
Arc-targeting miRNAs exhibit a somatodendritic
distribution and synaptoneurosomal localization
Arc mRNA is transported to dendrites where it can be locally
translated. If miRNAs directly regulate local Arc translation they
Figure 4. miR-34a, miR-326 and miR-193a downregulate Arc protein expression in cultured hippocampal neurons. Cultured
hippocampal neurons were transfected with either empty vector-DsRed, miR150-DsRed, miR34a-DsRed, miR326-DsRed or miR193a-DsRed. Neurons
were treated with BDNF for four hours and Arc protein expression was assessed by light microscopy. A) representative images of cells transfected
with empty vector-DsRed and miR34a-DsRed, respectively. Note that Arc levels are very diverse within one sample. The fields of view were chosen to
contain at least one DsRed-expressing neuron per image, and approximately 60 images from at least two different coverslips were taken per
condition per experiment. During image acquisition and subsequent data analysis, the experimenter was blinded to the treatment group of the cells.
B) scatter plots of Arc vs. DsRed levels per cell. Data are normalized to the average value of non-transfected cells. Gray diamonds = non-transfected
cells; black diamonds= transfected cells. n = 3996 cells from 3 experiments. C) bar graph comparing the average Arc level in transfected cells. Values
are normalized to the average Arc level in the non-transfected cells. A significant downregulation of Arc protein was seen in miR-34a transfected cells.
Significance was tested by independent t-tests, p,0.001. Error bars = SEM. n = 763 cells from 3 experiments. D) representative images of cells
transfected with miR-326-DsRed (cells labelled with DsRed and red arrows) and non-transfected cells (white arrows). Immunostaining of Arc protein is
visualized in blue. Note that Arc levels are very diverse within one sample. Phalloidin labelling in green was used to visualize the individual cells. E) bar
graph comparing the average Arc level in transfected cells. Values are normalized to the average Arc level in the non-transfected cells. A significant
downregulation of Arc protein was seen in miR-193a and miR-326 transfected cells. Significance was tested by univariate ANOVA and post hoc tests,
p,0.05. Error bars = SEM. n = 339 cells from 3 experiments.
doi:10.1371/journal.pone.0041688.g004
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should be present in dendrites. We therefore examined the
localization of Arc-targeting miRNA using qPCR analysis of the
dentate gyrus synaptoneurosome fraction and miRNA in situ
hybridization of brain sections. Synaptoneurosomes (SNs) were
derived by subcellullar fractionation of whole dentate gyrus lysates.
The SN fraction is enriched in pinched-off, resealed dendritic
spines attached to presynaptic boutons. Semiquantitive RT-PCR
was used to compare miRNA levels between the SN and total
homogenate. miR-124 was used as normalization control because
previous studies showed that miR-124 is neuron-specific and stably
expressed in SNs and homogenates obtained from adult mouse
forebrain [53]. We similarly observed equivalent expression of
miR-124 in SNs and lysate samples. To further validate the
preparation we measured levels of small nucleolar RNA
(snoRNA), a strictly nuclear RNA present in neurons and glia.
As shown in Figure 9A, the Arc-targeting microRNAs (miR-19a,
-32a, -326, -193a), exhibited SN/homogenate expression ratios
near 1 and were all significantly different from snoRNA with an
expression ratio of 0.15. The expression of Arc-targeting miRNAs
was not significantly different from that of the previously described
dendritic miRNAs, miR-132 and miR-134.
miRNA in situ hybridization was performed in coronal sections
of perfusion-fixed brains using specific locked-nucleic acid probes
(Figure 9B). Prominent miR-34a and miR-326 expression was
observed in the cell body layers of the dentate gyrus and
hippocampus proper. Dentate granule cells and hippocampal
pyramidal cells showed clear cytoplasmic, punctate staining. miR-
34a staining was also apparent in the proximal apical dendrites of
pyramidal cells, but not in dendrites of granule cells. There was
also no detectable dendritic staining for miR-326 (Fig. 9B). Taken
together, the results suggest that under basal (non-stimulated)
conditions the levels of miR-34a and miR-326 in distal dendrites is
much lower than in the cell body. This smaller pool of miRNAs is
detectable by qPCR in synaptoneurosomes but is probably below
the detection threshold for fluorescence in situ hybridization.
Discussion
The present study identifies microRNA regulators of Arc and
elucidates basic features of their activity-dependent expression and
subcellular localization. There are four main conclusions from this
work. 1) Arc expression is regulated by multiple miRNAs. This
was shown by ectopic miRNA expression in HEK cells and
hippocampal neurons and by inhibition of the endogenous
miRNAs in neurons. In addition, additive effects were obtained
by ectopic expression of specific miRNA pairs in HEK cells. 2)
During in vitro neuronal development there is an inverse
relationship between Arc mRNA expression and expression of
Arc-targeting miRNAs. Thus, at DIV10, expression of miR-19a,
miR-34a, miR-326 and miR-193a were decreased while Arc
mRNA was elevated. 3) Activity-dependent expression of Arc is
not accompanied by changes in steady state levels of mature, Arc-
targeting miRNAs. This conclusion is based on measurements of
miRNA levels in lysate samples from hippocampal neuronal
cultures treated with BDNF and from dentate gyrus after LTP
induction in vivo. Notably, both treatment paradigms induced the
BDNF-regulated miRNA, miR-132, in addition to Arc mRNA. 4)
Finally, Arc-targeting miRNAs are synaptically expressed. In situ
hybridization confirms miRNA expression in adult dentate
granule cells and hippocampal pyramidal cells, while qPCR
analysis shows enhanced expression of miR-19a, miR-34a, and
miR-326 in synaptoneurosomes relative to cell body restricted,
small nucleolar RNA.
Figure 5. Inhibition of endogenous Arc-targeting miRNAs in hippocampal neurons. PNA-conjugated antisense oligonucleotides were used
to block endogenous microRNAs. A) The uptake of a fluorescent control PNA oligo is efficient in hippocampal neurons (DIV8) 24 hours after
transfection. Green fluorescence= PNA. DsRed was cotransfected to compare the level of PNA transfection with that of plasmid. B) RNA enriched for
small RNAs was isolated 48 h after transfection of antisense and scrambled control PNA and the level of unbound microRNAs was assayed by real-
time PCR. 1% of miR-326, 0.7% of miR-34a and 4.7% of miR-193a remained unblocked after specific PNA transfection compared to control. Y1 was
used for normalization. Values are means of n = 3–46 SEM C) RNA was isolated 48 h after transfection of microRNA inhibitors and used for Arc mRNA
Q-PCR. Arc mRNA is significantly higher after transfection of miR-326 PNA-AS compared to scrambled (p = 0.04). Significance was tested by
independent t-tests. Data is normalized to polyubiquitin and cyclophilin. Values are means of n= 56 SEM. D) Proteins were harvested 48 h after PNA
transfection. Bar graphs representing densitometry measurements from protein western blot analysis. The Arc expression was normalized to the
expression of GAPDH. Values are means of n = 7 6 SEM.
doi:10.1371/journal.pone.0041688.g005
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Using an Arc 39UTR luciferase reporter in HEK cells we show
graded regulation of 16 miRNAs with predicted binding sites in
Arc. Mutations in the seed region of three miRNAs (miR-34a,
miR-326, and miR-19a) partially or fully rescue reporter
expression. In hippocampal neurons, miRNA overexpression
inhibits endogenous Arc protein expression in response to BDNF,
while inhibition of miR-326 facilitates Arc mRNA expression.
Collating results from mutation studies in HEK cells with effects of
miRNA manipulation in hippocampal neurons, we provide
evidence that miR-19a, miR-34a, miR-193a, and miR-326 are
capable of modulating Arc. Our analysis focused on a subset of
miRNAs that most effectively inhibit reporter expression or which
have a vertebrate-conserved binding site in Arc. It is certainly
possible that other microRNAs, though less effective in the
reporter assay, also modulate Arc.
Arc is a highly regulated gene system essential for long-term
synaptic plasticity, memory, and other adaptive changes in the
nervous system. Arc mRNA is induced as an immediate early gene
and transported to dendrites for local translation and degradation,
and Arc protein synthesis is necessary for consolidation of LTP,
long-term depression (LTD), and homeostatic plasticity. For these
reasons, Arc is attractive as a model for elucidating how miRNAs
interact with activity-induced mRNAs in the regulation of local
protein synthesis and specific functional outcomes like LTP and
LTD. Questions abound regarding the logic of Arc-targeting
miRNAs: 1) Are these miRNAs co-induced with Arc mRNA? 2)
Are the mature miRNAs deposited onto nascent Arc mRNA in the
Figure 6. Developmental regulation of Arc-targeting microRNAs. Arc mRNA expression and mature microRNA levels in hippocampal
neurons from E18 rat embryos at different developmental stages (days in vitro, DIV). A) Quantitative relative real-time PCR of Arc mRNA. Arc mRNA
increased at early time points and reached a plateau around DIV14. The relative values are expressed as fold change to DIV3 and normalized to the
geometric mean of the reference genes HRPT and cyclophilin. B) Quantitative relative real-time PCR of miR-19a, miR-34a, miR-326, miR-193a and miR-
132. The relative values are expressed as fold change to DIV3 and normalized to the reference genes snoRNA and Y1. At early stages of differentiation
there was an inverse relation between the expression of Arc mRNA and miR-34a, -19a, -326 and -193a expression. miR-132 expression increases with
neuronal differentiation. Note that the y-axis scale is in log format in B. In both A and B significance was tested by independent t-tests, p,0.05. Values
are means of n= 4 6 SEM. * significantly different from the preceding time point.
doi:10.1371/journal.pone.0041688.g006
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cell body or after transport of RNA into dendrites? 3) Are miRNAs
primarily used to silence Arc or as platforms for activity-dependent
derepression?
As recruitment of the miRISC could potentially destabilize Arc
mRNA and repress translation, it is relevant to consider current
knowledge of Arc mRNA stability and translational control.
Previous work has identified Arc mRNA as a physiological target
for nonsense-mediated RNA decay (NMD) [17]. The Arc 39UTR
has two introns and splicing of these introns results in the
deposition of the exon-junction complex near the stop codon and
recruitment of the NMD machinery during the first round of
translation. This form of translation-dependent degradation may
explain the rapid turnover of Arc mRNA and the tight coupling
between Arc transcription and protein expression during LTP
consolidation in the dentate gyrus in vivo [7,15,43]. Looking at
translation, in vitro studies show that specific Arc translation is
regulated at least in part by the RNA-binding protein, fragile-X
mental retardation protein (FMRP), which binds to the Arc
39UTR and to cytoplasmic FMRP-interacting protein (CYFIP)
[54]. By binding to eIF4E on the 59cap, CYFIP prevents
translation of FMRP bound mRNAs. This repression is relieved
by BDNF and metabotropic glutamate receptor signaling which
dislodge CYFIP/FMRP from the cap structure [54]. During in
vivo LTP, ERK signaling to MAP-kinase interacting kinase
(MNK) controls LTP consolidation, initiation complex formation,
and Arc synthesis [43]. Moreover, MNK triggers the release of
CYFIP/FMRP from eIF4E (Panja and Bramham, unpublished).
Arc also has a cis-acting A2 response-element (A2RE) in the
coding region that is specifically recognized by the heterogenous
ribonucleoproteins hnRNP A2 and hnRNP A/B and which
functions in the dendritic transport of Arc mRNA [55,56].
Functional interactions between miRNAs and RNA-binding
proteins have been shown for FMRP [57] and HuR, an AU-rich
element binding protein [58,59]. Theoretically, the additive effects
of specific miRNA pairs in regulating Arc could be related to the
position of the miRNA binding sites relative to each other and to
binding sites of RNA-binding proteins. However, there was no
obvious positional relationship that might explain our observa-
tions. miR-193a enhanced repression by both miR-34a and miR-
326. The seed binding site of miR-193a is close (5 nts) to the first
miR-326 site but 360 nts distant from miR-34a. miR-378 and
miR-34a also have a synergistic effect yet bind to quite widely
separated (1000 nt) sites. FMRP is of particular interest given work
on miRNA regulation of PSD95 translation in neurons, but the
FMRP recognition motif on the Arc 39UTR has yet to be
determined. The A2 response element in the coding region cannot
be a factor in our experiments on the Arc 39UTR reporter,
although the potential for miRNA regulation within the coding
region merits consideration.
Regarding the question of Arc/miRNA co-induction, the
present work demonstrates that Arc is robustly upregulated
without a concomitant change in the expression of the mature
miRNAs. This stands in contrast to miR-132 which is transcribed
in a synaptic activity-dependent manner and rapidly functions to
repress protein expression of synaptic proteins such as p250GAP
[60]. In terms of regulation of mRNA stability versus translation,
we show that inhibition of miR-326 in unstimulated neurons
enhances Arc mRNA expression without affecting protein,
indicating that miR-326 may specifically function to destabilize
Arc mRNA. The lack of effect of PNA-AS on Arc protein is
surprising, but may be related to the observed low levels of
endogenous miRNA expression at DIV10. Ectopic expression of
miR-193a, miR-326, and miR-34a all enhanced BDNF-evoked
Arc protein expression.
Research on miRNA metabolism in the nervous system has
focused primarily on biogenesis. However, the stability of mature
miRNA also appears to be highly regulated. While many miRNAs
are stable for long periods (weeks) in many cell types, recent work
suggests that some neuronal microRNAs turnover on the order of
minutes [23,25,27,61]. For example, mature miR-219 is down-
regulated 2 hours following NMDA receptor-dependent LTP
induction without any change in primary and precursor miR-219
[23]. The present work shows that Arc-targeting miRNAs are
constitutively expressed in the synaptoneurosome fraction. The
fact that these miRNAs are not co-induced with Arc mRNA in
whole dentate gyrus lysates favors the notion that Arc repression/
derepression is mediated by pre-existing mature miRNA, or by
local synaptic changes in miRNA metabolism.
Figure 7. BDNF does not alter levels of mature Arc-targeting miRNAs. The effect of BDNF stimulation (for 30 minutes or 3 hours) on
microRNA and Arc expression was studied at DIV8. A) Quantitative relative real-time PCR of Arc mRNA. The relative values are expressed as fold
change to untreated control cells and normalized to the reference genes HRPT, polyubiquitin and cyclophilin. Arc mRNA levels are significantly
increased at 30 minutes and 2 hours of BDNF treatment. B) Quantitative relative real-time PCR of miR- miR-133, 19a, miR-34a, miR-326 and miR-193a.
The relative values are expressed as fold change to untreated control cells and normalized to the reference genes snoRNA and Y1. The expression of
Arc-targeting miRNAs did not change in response to BDNF. Values are means of n = 46 SEM. In both A and B significance was tested by independent
t-tests, p,0.05. * significantly different from control.
doi:10.1371/journal.pone.0041688.g007
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miRNAs are often thought to act in a combinatorial manner on
multiple targets to sculpt protein expression that determines
specific cellular phenotypes or functions.
DIANA pathway analysis was done to predict biological
processes regulated by the five Arc-related miRNAs. Among the
top 10 process predicted were long-term potentiation, regulation
of the actin cytoskeleton, axon guidance, and ERK signaling (Supp
Figure S1). Interestingly miR-19, miR-34 and miR-326 are all
dysregulated in multiple sclerosis patients [62]. While little is
currently known about mir-193a and miR-19a, new studies have
shed light on miR-34 and miR-326 function in the nervous system.
miR-34 family microRNAs (miR-34a, -34b, -34c) share a
common seed sequence and therefore share many of the same
targets in many cell types. For instance, all three miR-34s
cooperate in inhibition of somatic cell reprogramming [63]. miR-
34a and 34b/c are suppressive in many tumor types and they
inhibit the epithelial-mesenchymal-transition [64–66]. Targets of
known or potential relevance in neuronal function and plasticity
include Notch1, histone deacetylase sirtuin1 (SIRT1), and growth
Figure 8. LTP-inducing stimulation does not alter the levels of mature Arc-targeting miRNAs. The effect of LTP induction in the dentate
gyrus on miRNA and Arc expression was studied by real-time PCR analysis of dentate gyrus samples obtained 30 min and 3 hours after high-
frequency stimulation (HFS) of the perforant path. A) Real-time PCR of Arc mRNA. Bar graphs indicate fold change in the HFS-treated dentate gyrus
relative to the control, contralateral dentate gyrus. Arc mRNA is induced 80-fold after HFS. Values are means of n= 26 SEM. The data was normalized
to the reference genes HRPT, polyubiquitin and cyclophilin. B) Quantitative relative real-time PCR of miR-19a, miR-34a, miR-326, miR-193a and miR-
132. miR-132 was significantly elevated at 2 h post-HFS. Bar graphs indicate fold change values comparing treated dentate gyrus relative to control.
Values are means of n = 5 6 SEM. Data has been normalized to the reference genes Y1. Significance was tested by independent t-tests. * p,0.05 and
significantly different from control.
doi:10.1371/journal.pone.0041688.g008
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factor signal transduction [67]. However, the miR-34 family genes
are differentially expressed and regulated. miR-34b and -34c are
co-transcribed from the same cluster distinct from the miR-34a
gene. In brain, miR-34a is developmentally upregulated through
embryonic and post-natal maturation under control of the p53
family transcription factor, TAp73 [68,69]. miR-34a negatively
regulates dendritic branching of immature cortical neurons in vitro
and downregulates expression of synaptotagmin and syntaxin.
miR-34a and miR-34c are also coexpressed following acute
restraint stress and chronic social defeat stress in mice. Virally-
mediated expression of miR-34c in the central nucleus of the
amygdala has anxiolytic effects, possibly through regulation of
corticotropin releasing factor [70]. Zhou et al showed that the
mood stabilizing drugs lithium and valproate downregulate miR-
34a, which in turn regulates expression of metabotropic glutamate
receptor 7 in hippocampal neurons [71]. Recent work elegantly
revealed a role for miR-34c in contextual fear conditioning, and
identified SIRT1 as a decisive target for this regulation [30]. The
authors point out that miR-34c may have other targets, referring
specifically to c-MYC [30,72]. Interestingly, Arc synthesis is also
required for contextual fear conditioning [73], and the present
work identifies Arc as another potentially important target for
miR-34a. In the present luciferase reporter analysis, overexpres-
sion of mir-34a and -34c both inhibited Arc, but only the 34a-
mediated inhibition was reversed by substitution mutation of the
seed region, suggesting a preferential interaction of miR-34a with
Arc.
miR-326 is expressed in neurons and works in a feedback loop
with Notch during development of the nervous system [74]. In the
adult brain, Notch is necessary for LTP and LTD, and proteolytic
activation of Notch in dendrites is dependent on Arc [75]. Thus,
miR-34a and miR-326 have Arc and Notch as common targets.
TargetScan further predicts a binding site for miR-326 in two
dendritically expressed RNAs with roles in synaptic plasticity,
protein kinase C-zeta and tissue plasminogen activator.
Future goals are to delineate the function of specific miRNA-
Arc interactions, and how this relates to the transcription,
processing, and decay of the miRNAs.
Supporting Information
Figure S1 Pathway analysis of Arc-targeting micro-
RNAs. Pathway analysis of Arc-targeting microRNAs was done
on DIANA mirPath using DIANA microT (Beta version) as the
target prediction tool. Histograms show different predicted
pathways potentially regulated by combined expression of the
miRNAs the score obtained is represented as 2ln(P-value).
Pathways with top ten scores have been plotted against 2ln(P-
value).
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Figure 9. Synaptic expression of Arc-targeting microRNAs. A) Synaptoneurosomes (SNs) were prepared from normal untreated dentate gyrus
and semi- quantitative relative real-time PCR was used to assess the synaptic localization of Arc-targeting miRNAs. Selected miRNAs were assayed in
total homogenate and in the synaptoneurosome fraction. miR-124a was equally expressed in both preparations and used to normalize the data.
Small nucleolar RNA (snoRNA) was highly depleted from the SN fraction and served as a quality control of the preparation. In contrast, the Arc-
associated miRNAs and a known dendritic miRNA, miR-132, showed similar SN/homogenate expression ratios. The relative values are expressed as
the fold enrichment between synaptoneurosomes and total homogenate. n = 6 Significance was tested by independent t-tests, p,0.05. *Significantly
different from total homogenate. Error bars = SEM. B) miRNA in situ hybridization was performed on coronal hippocampal sections using LNA probes
for miR-326, miR-34a, and scrambled control. miR-326 and miR-34a showed specific staining in the cell body layers of the dentate gyrus and cornu
ammonis (CA) regions compared to scramble control. For miR-34a, the staining was observed approximately 30 mm into the apical dendrites of CA1
pyramidal cells. Lower right panel shows CA1 region with examples of proximal dendritic staining marked by white arrows.
doi:10.1371/journal.pone.0041688.g009
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